Dr. Martin Neal Zaiac, MD

Dr. Zaiac practices at Martin N Zaiac, M.D. in Miami Beach, Florida.

Dr. Zaiac's NPI, 1215979398, was assigned on June 12, 2006. Dr. Zaiac graduated from Medical College Of Wisconsin in 1986. Dr. Zaiac holds Florida license ME00552008.

Dr. Zaiac's primary practice is Martin N Zaiac, M.D., at 4308 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 532-4478.

Dr. Zaiac's primary practice is Martin N Zaiac, M.D. in Miami Beach, Florida. Dr. Zaiac is also affiliated with Mount Sinai Medical Center. The medical group on file is Dermatology Group of Florida. Dmand AI also links Dr. Zaiac to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaiac practices, 4 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Zaiac's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Zaiac is board certified in dermatology by the American Board of Dermatology. Dr. Zaiac is licensed in Florida.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Zaiac treats.

CMS data shows 6,483 Medicare services from Dr. Zaiac across 27 procedure codes in 2024, for 818 Medicare patients. Medicare paid $390,780 for them. Every service was in an office.

CMS counts 818 Medicare patients who saw Dr. Zaiac in 2024. The largest group is 65 to 74, with 356 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zaiac's median patient age at 59, with 51% women.

In 2024, Dr. Zaiac wrote 1,160 Medicare Part D claims for 592 patients. 96% of them were for generic drugs. CMS names the drug for 963 of them, across 15 drugs with 11 or more claims each, at $14,638 in total drug cost. In 2023, CMS named 740 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zaiac for performance year 2024, reported individually. Dr. Zaiac accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zaiac as offering telehealth. CMS counts 368 procedures of skin biopsy by Dr. Zaiac, more than 93% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 66 papers to Dr. Zaiac, published from 2011 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Nail Diseases, Skin Neoplasms and Nails. Dr. Zaiac has published most often in J Am Acad Dermatol. Dr. Zaiac's most frequent co-authors are Antonella Tosti, MD, Mariya I. Miteva, MD and Shari Lipner.

CMS Open Payments shows 965 general payments to Dr. Zaiac from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Galderma Laboratories, L.P. paid the most, $19,555. It also lists 3 research payments totaling $10,365 from 2023 to 2025, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Zaiac.

Dr. Zaiac graduated from Medical College Of Wisconsin in 1986. Dr. Zaiac is a member of AAD and ASDS.

Dr. Zaiac is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.